Lee Tae-Eui, Shin Kyung-Chul, Oh Deok-Kun
Department of Bioscience and Biotechnology, Konkuk University, Seoul 05029, Republic of Korea.
J Microbiol Biotechnol. 2018 Mar 28;28(3):418-424. doi: 10.4014/jmb.1709.09044.
-Allose is a potential medical sugar because it has anticancer, antihypertensive, anti-inflammatory, antioxidative, and immunosuppressant activities. Allose production from fructose as a cheap substrate was performed by a one-pot reaction using -allulose 3-epimerase (FP-DAE) and ribose 5-phosphate isomerase (CT-RPI). The optimal reaction conditions for allose production were pH 7.5, 60°C, 0.1 g/l FP-DAE, 12 g/l CT-RPI, and 600 g/l fructose in the presence of 1 mM Co. Under these optimized conditions, FP-DAE and CT-RPI produced 79 g/l allose for 2 h, with a conversion yield of 13%. This is the first biotransformation of fructose to allose by a two-enzyme system. The production of allose by a one-pot reaction using FP-DAE and CT-RPI was 1.3-fold higher than that by a two-step reaction using the two enzymes.
阿洛糖是一种具有潜在医用价值的糖类,因为它具有抗癌、抗高血压、抗炎、抗氧化和免疫抑制活性。以果糖作为廉价底物,通过使用阿洛酮糖3-表异构酶(FP-DAE)和核糖5-磷酸异构酶(CT-RPI)的一锅法反应来生产阿洛糖。阿洛糖生产的最佳反应条件为pH 7.5、60°C、0.1 g/l FP-DAE、12 g/l CT-RPI以及在1 mM Co存在下600 g/l果糖。在这些优化条件下,FP-DAE和CT-RPI在2小时内生产出79 g/l阿洛糖,转化率为13%。这是首次通过双酶系统将果糖生物转化为阿洛糖。使用FP-DAE和CT-RPI通过一锅法反应生产阿洛糖的产量比使用这两种酶的两步法反应高出1.3倍。